ASCO 2026: Latest updates in mRCC

Omission of axillary lymph node dissection reduces arm morbidity without compromising survival in select breast cancer cases

ASCO 2026: Breast cancer overview

mRNA-4359 plus pembrolizumab shows high response rates and robust T-cell activation in melanoma

Combination therapeutic strategies for aRCC patients with bone metastases

Is radiotherapy a back up plan after neoadjuvant chemo-immunotherapy in perioperative lung cancer management?

Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing

Part 4: Clinical decision making - Interpretation of next generation sequencing results

Screen-detectable cancers account for majority of early-onset cancer cases under age 50

Perioperative anti–PD-L1 therapy improves event-free survival in resectable NSCLC with ctDNA-based risk stratification

Machine learning models improve prediction of immunotherapy outcomes across multiple cancer types

Denikitug shows immune activation and early anti-tumour activity in advanced solid tumour